Understanding how the proteasome, a key protein-degrading enzyme, is regulated
Regulation of Proteasome Activity
This study looks at how a special enzyme called the proteasome helps keep our cells healthy by breaking down certain proteins, and it aims to understand how changes in this enzyme can affect how long we live and how well we handle stress, using tiny creatures like worms and fruit flies to learn more about its role in diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10892977 on NIH RePORTER |
What this research studies
This research investigates the proteasome, an enzyme responsible for degrading proteins tagged for destruction by ubiquitin. It aims to uncover the mechanisms that regulate the proteasome's activity, which is crucial for maintaining cellular health and function. By studying model organisms like C. elegans and D. melanogaster, the research explores how variations in proteasome levels can influence lifespan and stress resistance. The findings could lead to new insights into how proteasome regulation impacts various diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to protein degradation disorders or those interested in the biological mechanisms of aging.
Not a fit: Patients with conditions unrelated to proteasome activity or those not affected by protein degradation issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for diseases linked to proteasome dysfunction, potentially improving patient outcomes.
How similar studies have performed: Previous research has shown that enhancing proteasome activity can significantly increase lifespan and stress resistance in model organisms, indicating a promising avenue for further exploration.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Finley, Daniel J — Harvard Medical School
- Study coordinator: Finley, Daniel J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.